98 related articles for article (PubMed ID: 7879259)
21. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
[TBL] [Abstract][Full Text] [Related]
22. Participation of RANTES and T-cell apoptosis in human renal allograft.
Racca A; Bailat A; García MI; Soutullo A; Gaite L; Malan Borel I
Scand J Immunol; 2005 Feb; 61(2):157-64. PubMed ID: 15683452
[TBL] [Abstract][Full Text] [Related]
23. Donor-specific hyporesponsiveness is observed in renal transplant patients who successfully maintain their renal function more than 6 years.
Kim YK; Ha J; Park MH; Kim SJ
Transplant Proc; 1996 Jun; 28(3):1235-6. PubMed ID: 8658639
[No Abstract] [Full Text] [Related]
24. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824
[TBL] [Abstract][Full Text] [Related]
25. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
26. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
27. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion.
Klaus G; Mostert K; Reckzeh B; Mueller TF
Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522
[TBL] [Abstract][Full Text] [Related]
29. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
30. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
Inston N; Drayson M; Ready A; Cockwell P
Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
[TBL] [Abstract][Full Text] [Related]
31. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.
Baan CC; Velthuis JH; van Gurp EA; Mol WM; Klepper M; Ijzermans JN; Weimar W
Clin Transplant; 2007; 21(1):63-71. PubMed ID: 17302593
[TBL] [Abstract][Full Text] [Related]
32. Peripheral tolerance in CD8+ T cells.
Srinivasan M; Frauwirth KA
Cytokine; 2009 May; 46(2):147-59. PubMed ID: 19268604
[TBL] [Abstract][Full Text] [Related]
33. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
[No Abstract] [Full Text] [Related]
34. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S; Daniel V; Dreikorn K; Röhl L
Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
[No Abstract] [Full Text] [Related]
35. Sequential study of immune mechanisms involved in graft acceptance in kidney transplantation.
Mestre M; Bas J; Massip E; Valls A; Castelao AM; Grinyó JM; Alsina J; Buendia E
Transplant Proc; 1995 Aug; 27(4):2371-3. PubMed ID: 7652843
[No Abstract] [Full Text] [Related]
36. 24-hour immunologic assessment of CD4+ and CD8+ lymphocytes in renal transplant recipients receiving chronic methylprednisolone.
Tornatore KM; Reed K; Venuto R
Clin Nephrol; 1995 Nov; 44(5):290-8. PubMed ID: 8605708
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the immune status in the recipients with long-term well-functioning kidneys allografts.
Nakagawa K; Matsuno T; Iwagaki H; Fujiwara T; Tanaka N
Acta Med Okayama; 2001 Feb; 55(1):31-9. PubMed ID: 11246975
[TBL] [Abstract][Full Text] [Related]
38. Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
Yamashita M; Aikawa A
Transplant Proc; 2000 Nov; 32(7):1768-72. PubMed ID: 11119927
[No Abstract] [Full Text] [Related]
39. Donor specific cell-mediated lympholysis (CML) by peripheral blood lymphocytes (PBL) from recipients with long-term renal grafts.
Imai T; Takasaki E; Beck Y; Inoue S; Tseng CC; Sugimoto H; Nagao T; Akiyama N; Uchida H
Transplant Proc; 1992 Aug; 24(4):1424-6. PubMed ID: 1386698
[No Abstract] [Full Text] [Related]
40. Detection of TIA-1 cytotoxic T-lymphocytes and epithelial apoptotic cells in renal allograft biopsies.
de Lajarte AS; Brun P; Baudouin V; Paris R; Loirat C; Peuchmaur M
Transplant Proc; 1995 Aug; 27(4):2474-5. PubMed ID: 7652891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
